Application
17075447 · PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE AND METHODS OF USING THE SAME
Filed 2020-10-20 · Granted · Patent 11504378 (2022-11-22) The official file ↗The patent and its PDF ↗ · Art unit 1613 · Examiner Doan Thi-Thuc Phan Typical · CPC A61K 9/1623 · Celgene Corporation · Celegene Corporation
Office actions
1
first was Restriction requirement
RCEs
0
no appeal
To first action
12.0 mo
to disposition 25.1 mo
Statutes raised
112 DP
1 actions read